EP Patent

EP3488847B1 — Semifluorinated alkane compositions

Assigned to Novaliq GmbH · Expires 2023-11-08 · 3y expired

What this patent protects

Patent listed against Miebo.

Drugs covered by this patent

Miebo (PERFLUOROHEXYLOCTANE) · Bausch Health

Patent Metadata

Patent number: EP3488847B1
Jurisdiction: EP
Classification: —
Expires: 2023-11-08
Drug substance claim: No
Drug product claim: No
Assignee: Novaliq GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.